U.S. FDA Suggests Multi-layered Approach To Combat Counterfeit Drugs
This article was originally published in PharmAsia News
Executive Summary
SEOUL - U.S. FDA is encouraging regulatory counterparts in Asia Pacific Economic Cooperation forum countries to adopt a multi-layered approach to combat counterfeit drugs